Dietary polyunsaturated fatty acids increase survival and decrease bacterial load during septic Staphylococcus aureus infection and improve neutrophil function in mice

Infection and Immunity

Volumn 83, Issue 2, 2015, Pages 514-521

  Svahn, Sara L ^a   Grahnemo, Louise ^a   Pálsdóttir, Vilborg ^a   Nookaew, Intawat ^b,c   Wendt, Karl ^a   Gabrielsson, Britt ^c   Schéle, Erik ^a   Benrick, Anna ^a   Andersson, Niklas ^a   Nilsson, Staffan ^c   Johansson, Maria E ^a   Jansson, John Olov ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b OAK RIDGE NATIONAL LABORATORY   (United States)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; POLYUNSATURATED FATTY ACID; PROTEIN; THIOGLYCOLIC ACID; CATHEPSIN D; EDIBLE OIL; THIOGLYCOLIC ACID DERIVATIVE; UNSATURATED FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL LOAD; BODY WEIGHT; BONE MARROW; BONE MARROW CELL; CARBOHYDRATE DIET; COMPARATIVE STUDY; CONTROLLED STUDY; FAT INTAKE; FAT MASS; INFLAMMATION; INOCULATION; LEUKOCYTE FUNCTION; LIPID COMPOSITION; LIPID DIET; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN INTAKE; SEPSIS; STAPHYLOCOCCUS INFECTION; STEM CELL; SURVIVAL; ADVERSE EFFECTS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED; CHEMOTAXIS; DIET; DRUG EFFECTS; IMMUNOLOGY; MICROBIOLOGY; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIAL LOAD; BONE MARROW CELLS; CATHEPSIN D; CHEMOTAXIS; DIET; DIET, HIGH-FAT; DIETARY FATS, UNSATURATED; FATTY ACIDS, UNSATURATED; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; THIOGLYCOLATES;

EID: 84921340585     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02349-14     Document Type: Article

References (32)

1. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2003. 2001 SCCM/ESICM/ACCP/ ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250-1256. http://dx.doi.org/10.1097/01.CCM.0000050454.01978.3B.
2. Russell JA. 2006. Management of sepsis. N Engl J Med 355:1699-1713. http://dx.doi.org/10.1056/NEJMra043632.
3. Martin GS, Mannino DM, Eaton S, Moss M. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546-1554. http://dx.doi.org/10.1056/NEJMoa022139.
4. Kotsaki A, Giamarellos-Bourboulis EJ. 2012. Emerging drugs for the treatment of sepsis. Expert Opin Emerg Drugs 17:379-391. http://dx.doi.org/10.1517/14728214.2012.697151.
5. Levy SB, Marshall B. 2004. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10:S122-S129. http://dx.doi.org/10.1038/nm1145.
6. WHO. 2012. The evolving threat of antimicrobial resistance-options of action. World Health Organization, Geneva, Switzerland.
7. Bone RC. 1992. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452-3455.
8. Remick DG. 2003. Cytokine therapeutics for the treatment of sepsis: why has nothing worked? Curr Pharm Des 9:75-82. http://dx.doi.org/10.2174/1381612033392567.
9. Hotchkiss RS, Karl IE. 2003. The pathophysiology and treatment of sepsis.N Engl J Med 348:138-150. http://dx.doi.org/10.1056/NEJMra021333.
10. Deitch EA. 1998. Animal models of sepsis and shock: a review and lessons learned. Shock 9:1-11.
11. Day RB, Link DC. 2012. Regulation of neutrophil trafficking from the bone marrow. Cell Mol Life Sci 69:1415-1423. http://dx.doi.org/10.1007/s00018-011-0870-8.
12. Nathan C. 2006. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6:173-182. http://dx.doi.org/10.1038/nri1785.
13. Miller LS, Cho JS. 2011. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 11:505-518. http://dx.doi.org/10.1038/nri3010.
14. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW. 1991. Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40:280-289.
15. Hu FB, Manson JE, Willett WC. 2001. Types of dietary fat and risk of coronary heart disease: a critical review. JAmColl Nutr 20:5-19. http://dx.doi.org/10.1080/07315724.2001.10719008.
16. Strandberg L, Verdrengh M, Enge M, Andersson N, Amu S, Onnheim K, Benrick A, Brisslert M, Bylund J, Bokarewa M, Nilsson S, Jansson JO. 2009. Mice chronically fed high-fat diet have increased mortality and disturbed immune response in sepsis. PLoS One 4:e7605. http://dx.doi.org/10.1371/journal.pone.0007605.
17. Kitagawa Y, Kikuchi S, Arita Y, Nishimura M, Mizuno K, Ogasawara H, Kawano T, Ochiai T, Otsuji E, Imai T. 2013. Inhibition of CCL20 increases mortality in models of mouse sepsis with intestinal apoptosis. Surgery 154:78-88. http://dx.doi.org/10.1016/j.surg.2013.02.012.
18. Ikuta K, Weissman IL. 1992. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci U S A 89:1502-1506. http://dx.doi.org/10.1073/pnas.89.4.1502.
19. Breslin WL, Strohacker K, Carpenter KC, Haviland DL, McFarlin BK. 2013. Mouse blood monocytes: standardizing their identification and analysis using CD115. J Immunol Methods 390:1-8. http://dx.doi.org/10.1016/j.jim.2011.03.005.
20. Smyth GK, Michaud J, Scott HS. 2005. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21:2067-2075. http://dx.doi.org/10.1093/bioinformatics/bti270.
21. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. 2001. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125:279-284. http://dx.doi.org/10.1016/S0166-4328(01)00297-2.
22. Conus S, Perozzo R, Reinheckel T, Peters C, Scapozza L, Yousefi S, Simon HU. 2008. Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation. J Exp Med 205:685-698. http://dx.doi.org/10.1084/jem.20072152.
23. Phillipson M, Kubes P. 2011. The neutrophil in vascular inflammation. Nat Med 17:1381-1390. http://dx.doi.org/10.1038/nm.2514.
24. Rigby KM, DeLeo FR. 2012. Neutrophils in innate host defense against Staphylococcus aureus infections. Semin Immunopathol 34:237-259. http://dx.doi.org/10.1007/s00281-011-0295-3.
25. Kent D, Copley M, Benz C, Dykstra B, Bowie M, Eaves C. 2008. Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway. Clin Cancer Res 14:1926-1930. http://dx.doi.org/10.1158/1078-0432.CCR-07-5134.
26. Levy J, Kolski GB, Douglas SD. 1989. Cathepsin D-like activity in neutrophils and monocytes. Infect Immun 57:1632-1634.
27. Roberg K, Kagedal K, Ollinger K. 2002. Microinjection of cathepsin D induces caspase-dependent apoptosis in fibroblasts. Am J Pathol 161:89-96. http://dx.doi.org/10.1016/S0002-9440(10)64160-0.
28. Bewley MA, Marriott HM, Tulone C, Francis SE, Mitchell TJ, Read RC, Chain B, Kroemer G, Whyte MK, Dockrell DH. 2011. A cardinal role for cathepsin D in co-ordinating the host-mediated apoptosis of macrophages and killing of pneumococci. PLoS Pathog 7:e1001262. http://dx.doi.org/10.1371/journal.ppat.1001262.
29. del Cerro-Vadillo E, Madrazo-Toca F, Carrasco-Marin E, Fernandez-Prieto L, Beck C, Leyva-Cobian F, Saftig P, Alvarez-Dominguez C. 2006. Cutting edge: a novel nonoxidative phagosomal mechanism exerted by cathepsin-D controls Listeria monocytogenes intracellular growth. JImmunol176: 1321-1325. http://dx.doi.org/10.4049/jimmunol.176.3.1321.
30. Ogle CK, Ogle JD, Mao JX, Simon J, Noel JG, Li BG, Alexander JW. 1994. Effect of glutamine on phagocytosis and bacterial killing by normal and pediatric burn patient neutrophils. J Parenter Enteral Nutr 18:128-133.
31. Wilmore DW, Shabert JK. 1998. Role of glutamine in immunologic responses. Nutrition 14:618-626. http://dx.doi.org/10.1016/S0899-9007(98)00009-4.
32. Suzuki I, Matsumoto Y, Adjei AA, Asato L, Shinjo S, Yamamoto S. 1993. Effect of a glutamine-supplemented diet on response to methicillinresistant Staphylococcus aureus infection in mice. J Nutr Sci Vitaminol 39:405-410. http://dx.doi.org/10.3177/jnsv.39.405.